FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2960360023> ?p ?o ?g. }

• W2960360023 endingPage "4637" @default.
• W2960360023 startingPage "4627" @default.
• W2960360023 abstract "Abstract Telomerase is expressed in the majority (&gt;85%) of tumors, but has restricted expression in normal tissues. Long-term telomerase inhibition in malignant cells results in progressive telomere shortening and reduction in cell proliferation. Here we report the synthesis and characterization of radiolabeled oligonucleotides that target the RNA subunit of telomerase, hTR, simultaneously inhibiting enzymatic activity and delivering radiation intracellularly. Oligonucleotides complementary (Match) and noncomplementary (Scramble or Mismatch) to hTR were conjugated to diethylenetriaminepentaacetic dianhydride (DTPA), allowing radiolabeling with the Auger electron-emitting radionuclide indium-111 (111In). Match oligonucleotides inhibited telomerase activity with high potency, which was not observed with Scramble or Mismatch oligonucleotides. DTPA-conjugation and 111In-labeling did not change telomerase inhibition. In telomerase-positive cancer cells, unlabeled Match oligonucleotides had no effect on survival, however, 111In-labeled Match oligonucleotides significantly reduced clonogenic survival and upregulated the DNA damage marker γH2AX. Minimal radiotoxicity and DNA damage was observed in telomerase-negative cells exposed to 111In-Match oligonucleotides. Match oligonucleotides localized in close proximity to nuclear Cajal bodies in telomerase-positive cells. In comparison with Match oligonucleotides, 111In-Scramble or 111In-Mismatch oligonucleotides demonstrated reduced retention and negligible impact on cell survival. This study indicates the therapeutic activity of radiolabeled oligonucleotides that specifically target hTR through potent telomerase inhibition and DNA damage induction in telomerase-expressing cancer cells and paves the way for the development of novel oligonucleotide radiotherapeutics targeting telomerase-positive cancers. Significance: These findings present a novel radiolabeled oligonucleotide for targeting telomerase-positive cancer cells that exhibits dual activity by simultaneously inhibiting telomerase and promoting radiation-induced genomic DNA damage." @default.
• W2960360023 created "2019-07-23" @default.
• W2960360023 creator A5022905339 @default.
• W2960360023 creator A5051519947 @default.
• W2960360023 creator A5061519541 @default.
• W2960360023 creator A5068579148 @default.
• W2960360023 creator A5074404084 @default.
• W2960360023 creator A5074565235 @default.
• W2960360023 creator A5078642688 @default.
• W2960360023 creator A5089197662 @default.
• W2960360023 date "2019-09-13" @default.
• W2960360023 modified "2023-10-03" @default.
• W2960360023 title "Radiolabeled Oligonucleotides Targeting the RNA Subunit of Telomerase Inhibit Telomerase and Induce DNA Damage in Telomerase-Positive Cancer Cells" @default.
• W2960360023 cites W1609499351 @default.
• W2960360023 cites W1653629301 @default.
• W2960360023 cites W1666093095 @default.
• W2960360023 cites W1915004688 @default.
• W2960360023 cites W1965743650 @default.
• W2960360023 cites W1966524413 @default.
• W2960360023 cites W1966933830 @default.
• W2960360023 cites W1966935558 @default.
• W2960360023 cites W1971063258 @default.
• W2960360023 cites W1972393066 @default.
• W2960360023 cites W1982129270 @default.
• W2960360023 cites W1985775217 @default.
• W2960360023 cites W1987747515 @default.
• W2960360023 cites W1988327952 @default.
• W2960360023 cites W1988399759 @default.
• W2960360023 cites W1990909310 @default.
• W2960360023 cites W1991893451 @default.
• W2960360023 cites W2001051598 @default.
• W2960360023 cites W2002419101 @default.
• W2960360023 cites W2007071422 @default.
• W2960360023 cites W2007306805 @default.
• W2960360023 cites W2007613355 @default.
• W2960360023 cites W2013073993 @default.
• W2960360023 cites W2015958589 @default.
• W2960360023 cites W2018182154 @default.
• W2960360023 cites W2022893313 @default.
• W2960360023 cites W2025783385 @default.
• W2960360023 cites W2033425827 @default.
• W2960360023 cites W2036235842 @default.
• W2960360023 cites W2045653120 @default.
• W2960360023 cites W2047582165 @default.
• W2960360023 cites W2047619014 @default.
• W2960360023 cites W2062955305 @default.
• W2960360023 cites W2066302687 @default.
• W2960360023 cites W2089583243 @default.
• W2960360023 cites W2093249575 @default.
• W2960360023 cites W2096712048 @default.
• W2960360023 cites W2103172804 @default.
• W2960360023 cites W2117692326 @default.
• W2960360023 cites W2118228848 @default.
• W2960360023 cites W2129992844 @default.
• W2960360023 cites W2130657959 @default.
• W2960360023 cites W2148496296 @default.
• W2960360023 cites W2156857444 @default.
• W2960360023 cites W2156857490 @default.
• W2960360023 cites W2170426698 @default.
• W2960360023 cites W2175017274 @default.
• W2960360023 cites W2321647501 @default.
• W2960360023 cites W2336977304 @default.
• W2960360023 cites W2465907273 @default.
• W2960360023 cites W2517999123 @default.
• W2960360023 cites W2518827737 @default.
• W2960360023 cites W2547163348 @default.
• W2960360023 cites W2591294588 @default.
• W2960360023 cites W2755501245 @default.
• W2960360023 doi "https://doi.org/10.1158/0008-5472.can-18-3594" @default.
• W2960360023 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7611324" @default.
• W2960360023 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31311806" @default.
• W2960360023 hasPublicationYear "2019" @default.
• W2960360023 type Work @default.
• W2960360023 sameAs 2960360023 @default.
• W2960360023 citedByCount "13" @default.
• W2960360023 countsByYear W29603600232020 @default.
• W2960360023 countsByYear W29603600232021 @default.
• W2960360023 countsByYear W29603600232022 @default.
• W2960360023 countsByYear W29603600232023 @default.
• W2960360023 crossrefType "journal-article" @default.
• W2960360023 hasAuthorship W2960360023A5022905339 @default.
• W2960360023 hasAuthorship W2960360023A5051519947 @default.
• W2960360023 hasAuthorship W2960360023A5061519541 @default.
• W2960360023 hasAuthorship W2960360023A5068579148 @default.
• W2960360023 hasAuthorship W2960360023A5074404084 @default.
• W2960360023 hasAuthorship W2960360023A5074565235 @default.
• W2960360023 hasAuthorship W2960360023A5078642688 @default.
• W2960360023 hasAuthorship W2960360023A5089197662 @default.
• W2960360023 hasBestOaLocation W29603600231 @default.
• W2960360023 hasConcept C104292427 @default.
• W2960360023 hasConcept C104317684 @default.
• W2960360023 hasConcept C121608353 @default.
• W2960360023 hasConcept C125593758 @default.
• W2960360023 hasConcept C129312508 @default.
• W2960360023 hasConcept C143425029 @default.
• W2960360023 hasConcept C153911025 @default.
• W2960360023 hasConcept C177336024 @default.
• W2960360023 hasConcept C185592680 @default.

• next